ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma-Reference-Cited by-同舟云学术

ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma

Published:2018-12-24 Issue:2 Volume:247 Page:266-278
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Chen Qian¹,Weng Hai-Yan²,Tang Xiao-Peng³,Lin Yong¹,Yuan Ye¹,Li Qian¹,Tang Zhuo¹,Wu Hai-Bo¹,Yang Shuai¹,Li Yong¹,Zhao Xi-Long¹,Fu Wen-Juan¹,Niu Qin¹,Feng Hua⁴,Zhang Xia¹,Wang Yan¹,Bian Xiu-Wu¹,Yao Xiao-Hong¹

Affiliation:

1. Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University); Chongqing PR China

2. Department of Pathology; The Affiliated Provincial Hospital, Anhui Medical University; Hefei PR China

3. Department of Nephrology; Southwest Hospital, Third Military Medical University (Army Medical University); Chongqing PR China

4. Department of Neurosurgery; Southwest Hospital, Third Military Medical University (Army Medical University); Chongqing PR China

Funder

National Key Research and Development Program

National Natural Science Foundation of China

the Open Project of the Key Laboratory of Tumor Immunopathology, Ministry of Education of China

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.5189/fullpdf

Reference42 articles.

1. The 2016 World Health Organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol,2016

2. PTEN signaling pathways in glioblastoma;Koul;Cancer Biol Ther,2008

3. Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors;Bianco;Oncogene,2003

4. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors;Mellinghoff;N Engl J Med,2005

5. PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients;Nagata;Cancer Cell,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of ARL4C in predicting prognosis and immunotherapy drug susceptibility in pan-cancer analysis;Frontiers in Pharmacology;2023-12-20

2. Ursolic acid inhibits the metastasis of colon cancer by downregulating ARL4C expression;Oncology Reports;2023-12-18

3. Whole Transcriptome Analysis of Substantia Nigra in Mice with MPTP-Induced Parkinsonism Bearing Defective Glucocerebrosidase Activity;International Journal of Molecular Sciences;2023-07-29

4. Stepwise activation of p63 and the MEK/ERK pathway induces the expression of ARL4C to promote oral squamous cell carcinoma cell proliferation;Pathology - Research and Practice;2023-06

5. The role of Wnt, ARL4C, and Sema3A in developmental process and disease pathogenesis;Pathology International;2023-04-26